HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Paracetamol And Pregnancy: No Packaging Updates Needed, EU Regulators Decide

Executive Summary

Following a review of a recent study warning against paracetamol use by pregnant women, the heads of European Union medicines agencies have decided that the evidence was "inconclusive" and therefore no product patient information updates are necessary. 

You may also be interested in...



Researchers Urge Review Of Soluble Paracetamol Based On Increased Sodium-Related CVD Risk

High sodium content in effervescent paracetamol could increase risk of cardiovascular disease and mortality in people with and without hypertension, says a recently published study. The authors of the study recommend that the safety profile of such products be reviewed.

Ibuprofen Better Than Paracetamol At Reducing Fever In Children And Just As Safe – Study

A meta-analysis finds moderate-quality evidence that compared with paracetamol (also known as acetaminophen), ibuprofen is more effective at reducing fever in children under two years old, and despite concerns, has a similar safety profile.

Paracetamol Safety Backed By Council Of Europe

Council of Europe Directorate EDQM finds popular paracetamol products sold in the Netherlands and manufactured in China do not contain unsafe levels of a possible human carcinogen as reported in the Dutch media.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel